190 related articles for article (PubMed ID: 4390668)
1. Myocardial and haemodynamic effects of the beta-adrenoceptor blocking drug alprenolol (H56/28) in anaesthetized cats.
Parratt JR; Wadsworth RM
Br J Pharmacol; 1969 Oct; 37(2):357-66. PubMed ID: 4390668
[TBL] [Abstract][Full Text] [Related]
2. The effect of catecholamine infusions on myocardial blood flow, metabolic heat production and on general haemodynamics, before and after alprenolol (H56-28), in anaesthetized cats.
Parratt JR; Wadsworth RM
Br J Pharmacol; 1970 May; 38(3):554-71. PubMed ID: 4392541
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular pharmacology of quazodine (MJ-1988), with particular reference to effects of myocardial blood flow and metabolic heat production.
Parratt JR; Winslow E
Br J Pharmacol; 1971 Jun; 42(2):193-204. PubMed ID: 4397441
[TBL] [Abstract][Full Text] [Related]
4. Myocardial and haemodynamic effects of phentolamine.
Das PK; Parratt JR
Br J Pharmacol; 1971 Mar; 41(3):437-44. PubMed ID: 4396969
[TBL] [Abstract][Full Text] [Related]
5. The effect of "selective" beta-adrenoceptor blocking drugs on the myocardial circulation.
Parratt JR; Wadsworth RM
Br J Pharmacol; 1970 Jun; 39(2):296-308. PubMed ID: 4393214
[TBL] [Abstract][Full Text] [Related]
6. Myocardial and circulatory effects of E. coli endotoxin; modification of responses to catecholamines.
Parratt JR
Br J Pharmacol; 1973 Jan; 47(1):12-25. PubMed ID: 4123817
[TBL] [Abstract][Full Text] [Related]
7. The effects of nisoldipine (Bay K 5552) on cardiovascular performance and regional blood flow in pentobarbital-anaesthetized pigs with or without beta-adrenoceptor blockade.
Duncker DJ; Hartog JM; Hugenholtz PG; Saxena PR; Verdouw PD
Br J Pharmacol; 1986 May; 88(1):9-18. PubMed ID: 2871886
[TBL] [Abstract][Full Text] [Related]
8. Central haemodynamic effects in man of intravenous d-alprenolol during rest and exercise.
Ekelund LG; Melcher A; Orö L
Eur J Clin Pharmacol; 1971 Sep; 3(4):198-203. PubMed ID: 5151303
[No Abstract] [Full Text] [Related]
9. [Effect of a new beta-receptor blockader (LB 46, Visken) on systemic and pulmonary hemodynamics and on coronary blood flow in humans].
Dolder M; Kaufmann M; Gurtner HP
Schweiz Med Wochenschr; 1971 Dec; 101(51):1869-76. PubMed ID: 4400986
[No Abstract] [Full Text] [Related]
10. Studies on the mode of action of hexobendine, a prospective anti-anginal drug.
McInnes L; Parratt JR
Br J Pharmacol; 1969 Sep; 37(1):272-82. PubMed ID: 5343351
[TBL] [Abstract][Full Text] [Related]
11. Nutritional circulation in the heart. 3. Effect of isoproterenol and beta adrenergic blockade on myocardial hemodynamics and rubicium-86 extraction in the isolated supported heart preparation.
Somani P; Laddu AR; Hardm HF
J Pharmacol Exp Ther; 1970 Dec; 175(3):577-92. PubMed ID: 4395225
[No Abstract] [Full Text] [Related]
12. Effects of alprenolol, bunolol and propranolol on pulmonary resistance in the anaesthetized dog.
Giles RE; Finkel MP
Eur J Pharmacol; 1971 Oct; 16(2):155-63. PubMed ID: 4405779
[No Abstract] [Full Text] [Related]
13. Comparison of the effects of dexmedetomidine and esmolol on myocardial oxygen consumption in dogs.
Willigers HM; Prinzen FW; Roekaerts PM
Eur J Anaesthesiol; 2004 Dec; 21(12):957-66. PubMed ID: 15719859
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the beta adrenergic blocking activities of propranolol and inpea.
Hahn RA; Pendleton RG; Wardell JR
J Pharmacol Exp Ther; 1968 May; 161(1):111-21. PubMed ID: 5648488
[No Abstract] [Full Text] [Related]
15. Effects of catecholamines, exercise, and nitroglycerin on the normal and ischemic myocardium in conscious dogs.
Vatner SF; McRitchie RJ; Maroko PR; Patrick TA; Braunwald E
J Clin Invest; 1974 Sep; 54(3):563-75. PubMed ID: 4152859
[TBL] [Abstract][Full Text] [Related]
16. Circulatory responses to beta adrenergic blockade with alprenolol. Studies in patients with chronic heart disease.
Kerber RE; Goldman RH; Alderman EL; Harrison DC
Am J Cardiol; 1972 Jan; 29(1):26-32. PubMed ID: 4399889
[No Abstract] [Full Text] [Related]
17. Effects of niguldipine, a new dihydropyridine calcium antagonist, on regional blood flow, cardiac performance and myocardial metabolism in anaesthetized open-chest dogs.
Fischer G; Schneider W; Krumpl G; Grohs JG; Raberger G
Arch Int Pharmacodyn Ther; 1989; 298():96-107. PubMed ID: 2757470
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
Brunner H; Hedwall PR; Meier M
Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
[No Abstract] [Full Text] [Related]
19. [Effect of beta-adrenoblockaders on the coronary circulation in dogs].
Khomaziuk AI; Gorodinskaia VIa
Kardiologiia; 1969 Aug; 9(8):77-83. PubMed ID: 4392059
[No Abstract] [Full Text] [Related]
20. Effects of three beta adrenergic receptor blockers on myocardial oxygen consumption in the dog.
Ek L; Ablad B
Eur J Pharmacol; 1971; 14(1):19-28. PubMed ID: 4396658
[No Abstract] [Full Text] [Related]
[Next] [New Search]
